Caprico Biotechnologies Caprico Biotechnologies (CBI) is a biotech company focused on developing and commercializing antibody reagents for flow cytometry applications. | ![]() Bristol Myers Squibb Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. | ![]() Biosonda Biosonda is a biotechnology company that specializes in the research, development, production, and commercialization of hemocyanins. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | |
Founding Date | Founding Date 2013 | Founding Date 1887 | Founding Date 1992 | Founding Date 1996 | Founding Date 1849 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Norcross, US HQ | Locations Princeton, US HQ Mulgrave, AU Pinewood, AU Wien, AT Braine L'alleud, BE Bruxelles, BE São Paulo, BR see more | Locations Miami, US HQ Ñuñoa, CL | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more |
Employees | Employees 17 | Employees 34,100 | Employees N/A | Employees 75,883 | Employees 81,0008% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 97.8 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 163.9 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $48.2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $13.9b (FY, 2025) | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) | Cost of goods $16.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $34.3b (FY, 2025) | Gross profit N/A | Gross profit $49.8b (FY, 2025) | Gross profit $46.5b (FY, 2025) |
Net income | Net income N/A | Net income $7.1b (FY, 2025) | Net income N/A | Net income $14b (FY, 2025) | Net income $7.8b (FY, 2025) |
Operating ⚠ | |||||
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 32 (FY, 2024) |
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 7 (FY, 2021) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 27 (FY, 2021) | Phase III Trials Products (Oncology) N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products 5 (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 15.5m | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised N/A |

Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
View company
Biosonda is a biotechnology company that specializes in the research, development, production, and commercialization of hemocyanins.
View company
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company